Nifty
:
25244.75
Sensex
:
82755.51
200.40 (0.80%)
700.40 (0.85%)
Nifty
Sensex
:
:
25244.75
82755.51
200.40 (0.80%)
700.40 (0.85%)

Bharat Parenterals Ltd.

Pharmaceuticals & Drugs

Rating :
40/99

BSE: 541096 | NSE: Not Listed

NSE BSE
1125.00
24-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1119.3
  •  1130
  •  1110
  •  1119.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  842
  •  943616
  •  1130
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 775.35
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 897.96
  • 0.09%
  • 2.34

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.20%
  • 8.46%
  • 18.94%
  • FII
  • DII
  • Others
  • 0.11%
  • 0.00%
  • 5.29%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.91
  • 2.44
  • 6.67

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.31
  • -3.43
  • -3.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.75
  • -9.68
  • -11.66

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 10.52
  • 13.31

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 1.94
  • 2.22

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 18.79
  • 27.64

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
103.98
67.82
53.32%
72.26
59.82
20.80%
71.63
59.81
19.76%
92.51
69.91
32.33%
Expenses
101.74
66.82
52.26%
68.62
53.21
28.96%
79.28
55.48
42.90%
88.02
59.46
48.03%
EBITDA
2.24
1.00
124.00%
3.64
6.61
-44.93%
-7.65
4.33
-
4.49
10.45
-57.03%
EBIDTM
2.15%
1.47%
5.04%
11.05%
-10.68%
7.24%
4.85%
14.95%
Other Income
1.92
2.64
-27.27%
2.95
1.26
134.13%
4.20
2.59
62.16%
2.54
2.10
20.95%
Interest
3.94
1.13
248.67%
3.33
0.58
474.14%
2.91
0.63
361.90%
2.77
0.89
211.24%
Depreciation
8.52
3.87
120.16%
8.76
1.82
381.32%
9.01
1.75
414.86%
9.03
1.58
471.52%
PBT
-8.30
-1.36
-
-5.50
5.47
-
-15.37
4.54
-
-4.77
10.08
-
Tax
1.14
1.20
-5.00%
2.37
1.83
29.51%
2.15
2.11
1.90%
4.07
3.07
32.57%
PAT
-9.44
-2.56
-
-7.87
3.64
-
-17.52
2.43
-
-8.84
7.01
-
PATM
-9.08%
-3.77%
-10.89%
6.08%
-24.46%
4.06%
-9.56%
10.03%
EPS
-6.87
-0.52
-
-2.41
6.55
-
-11.51
6.05
-
1.96
13.02
-84.95%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
340.38
257.36
217.98
212.01
204.64
228.18
219.54
136.58
111.44
124.11
Net Sales Growth
32.26%
18.07%
2.82%
3.60%
-10.32%
3.94%
60.74%
22.56%
-10.21%
 
Cost Of Goods Sold
185.48
158.35
137.48
136.07
134.27
148.91
140.48
88.18
79.07
83.01
Gross Profit
154.90
99.01
80.50
75.95
70.38
79.26
79.06
48.39
32.37
41.10
GP Margin
45.51%
38.47%
36.93%
35.82%
34.39%
34.74%
36.01%
35.43%
29.05%
33.12%
Total Expenditure
337.66
234.14
197.99
184.10
179.40
200.53
190.69
124.44
104.98
114.12
Power & Fuel Cost
-
4.69
3.75
3.21
3.10
3.19
2.70
2.62
1.79
2.06
% Of Sales
-
1.82%
1.72%
1.51%
1.51%
1.40%
1.23%
1.92%
1.61%
1.66%
Employee Cost
-
22.78
18.00
15.37
14.75
15.58
15.37
12.94
11.37
9.10
% Of Sales
-
8.85%
8.26%
7.25%
7.21%
6.83%
7.00%
9.47%
10.20%
7.33%
Manufacturing Exp.
-
13.15
11.16
8.43
7.35
8.60
9.12
5.01
4.07
3.78
% Of Sales
-
5.11%
5.12%
3.98%
3.59%
3.77%
4.15%
3.67%
3.65%
3.05%
General & Admin Exp.
-
8.40
6.21
3.09
2.53
2.88
3.47
1.91
1.46
4.54
% Of Sales
-
3.26%
2.85%
1.46%
1.24%
1.26%
1.58%
1.40%
1.31%
3.66%
Selling & Distn. Exp.
-
17.73
16.34
7.72
7.30
12.04
13.62
9.50
4.47
10.22
% Of Sales
-
6.89%
7.50%
3.64%
3.57%
5.28%
6.20%
6.96%
4.01%
8.23%
Miscellaneous Exp.
-
9.03
5.06
10.21
10.10
9.34
5.93
4.27
2.74
1.42
% Of Sales
-
3.51%
2.32%
4.82%
4.94%
4.09%
2.70%
3.13%
2.46%
1.14%
EBITDA
2.72
23.22
19.99
27.91
25.24
27.65
28.85
12.14
6.46
9.99
EBITDA Margin
0.80%
9.02%
9.17%
13.16%
12.33%
12.12%
13.14%
8.89%
5.80%
8.05%
Other Income
11.61
8.59
12.04
7.93
8.68
11.90
12.74
7.17
7.71
5.05
Interest
12.95
4.07
2.60
1.31
0.77
0.86
0.87
0.94
0.91
1.49
Depreciation
35.32
9.02
5.88
6.66
6.03
5.88
6.13
5.57
5.79
4.20
PBT
-33.94
18.72
23.55
27.88
27.12
32.80
34.59
12.79
7.48
9.35
Tax
9.73
8.21
7.83
7.06
6.81
8.65
13.35
3.68
0.59
2.89
Tax Rate
-28.67%
43.86%
33.25%
25.32%
25.11%
26.37%
38.59%
28.77%
7.89%
30.91%
PAT
-43.67
14.51
16.39
21.05
20.39
24.14
21.25
9.12
6.89
6.45
PAT before Minority Interest
-12.62
10.51
15.71
20.81
20.32
24.14
21.25
9.12
6.89
6.45
Minority Interest
31.05
4.00
0.68
0.24
0.07
0.00
0.00
0.00
0.00
0.00
PAT Margin
-12.83%
5.64%
7.52%
9.93%
9.96%
10.58%
9.68%
6.68%
6.18%
5.20%
PAT Growth
-515.11%
-11.47%
-22.14%
3.24%
-15.53%
13.60%
133.00%
32.37%
6.82%
 
EPS
-63.29
21.03
23.75
30.51
29.55
34.99
30.80
13.22
9.99
9.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
197.27
182.80
165.83
143.87
118.19
94.01
72.85
63.68
56.69
Share Capital
5.82
5.77
5.77
5.73
5.73
5.73
5.73
5.73
5.73
Total Reserves
191.45
176.49
160.05
137.71
112.46
88.28
67.12
57.95
50.96
Non-Current Liabilities
75.15
12.65
14.38
11.21
3.42
4.42
0.22
3.29
7.39
Secured Loans
73.16
10.92
9.75
8.59
0.71
0.97
2.34
3.67
6.57
Unsecured Loans
0.00
0.00
2.74
0.00
0.00
0.00
0.00
0.34
0.33
Long Term Provisions
2.10
1.33
0.94
0.64
0.51
0.09
0.08
0.00
0.00
Current Liabilities
190.38
119.80
41.53
43.63
65.88
60.51
56.88
42.79
56.18
Trade Payables
60.03
51.34
23.76
26.17
42.61
31.91
26.56
36.37
38.84
Other Current Liabilities
47.71
30.83
13.00
15.42
22.60
25.93
22.22
6.22
0.37
Short Term Borrowings
80.85
36.02
2.78
1.19
0.00
1.95
4.98
0.00
12.53
Short Term Provisions
1.80
1.60
1.99
0.84
0.67
0.71
3.13
0.21
4.44
Total Liabilities
503.71
350.35
226.06
198.66
187.49
158.94
129.95
109.76
120.26
Net Block
209.48
41.19
39.75
43.36
31.75
33.98
33.71
31.16
34.69
Gross Block
255.58
80.07
72.98
71.05
53.58
50.12
44.11
35.99
62.47
Accumulated Depreciation
46.10
38.88
33.22
27.69
21.83
16.14
10.40
4.83
27.78
Non Current Assets
243.80
166.06
82.32
50.63
55.88
40.91
39.12
45.78
48.64
Capital Work in Progress
24.94
99.01
25.65
0.44
12.16
1.06
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
1.31
1.36
0.00
0.55
0.50
Long Term Loans & Adv.
6.06
22.33
13.49
2.77
7.93
1.95
2.85
9.71
9.30
Other Non Current Assets
2.42
2.54
2.34
2.86
2.73
2.56
2.57
4.35
4.15
Current Assets
259.91
184.28
143.74
148.02
131.62
118.02
90.83
63.98
71.62
Current Investments
0.00
0.00
11.48
42.79
0.01
1.47
0.52
0.00
0.00
Inventories
61.47
37.84
20.76
22.43
28.82
22.52
14.43
15.27
14.12
Sundry Debtors
141.42
112.41
73.40
67.83
79.35
63.87
58.65
43.60
44.06
Cash & Bank
12.09
9.98
4.68
2.43
10.40
12.13
4.13
1.58
12.74
Other Current Assets
44.93
0.74
1.70
0.45
13.04
18.03
13.10
3.53
0.69
Short Term Loans & Adv.
43.84
23.31
31.71
12.09
12.59
17.52
12.57
0.20
0.12
Net Current Assets
69.53
64.49
102.20
104.40
65.74
57.51
33.94
21.20
15.44
Total Assets
503.71
350.34
226.06
198.65
187.50
158.93
129.95
109.76
120.26

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-4.71
21.66
-1.07
24.45
14.45
20.43
6.34
-2.11
0.00
PBT
18.72
23.55
27.88
27.12
32.80
34.59
12.79
7.48
0.00
Adjustment
15.33
8.81
4.85
10.37
6.23
6.63
6.27
5.88
0.00
Changes in Working Capital
-29.29
-1.90
-28.13
-6.37
-14.53
-10.36
-10.17
-13.88
0.00
Cash after chg. in Working capital
4.76
30.46
4.60
31.12
24.50
30.87
8.89
-0.52
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-9.46
-8.79
-5.67
-6.68
-10.04
-10.44
-2.56
-1.59
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-104.78
-77.82
-6.63
-43.37
-12.60
-9.35
-8.07
-1.53
0.00
Net Fixed Assets
-7.78
-0.52
-2.55
-5.31
-14.56
-7.07
-8.12
26.48
Net Investments
-10.21
-22.10
25.52
-40.25
1.51
-2.31
0.03
-0.30
Others
-86.79
-55.20
-29.60
2.19
0.45
0.03
0.02
-27.71
Cash from Financing Activity
110.43
60.60
9.42
10.50
-2.82
-3.89
4.04
-7.52
0.00
Net Cash Inflow / Outflow
0.94
4.44
1.72
-8.43
-0.96
7.18
2.30
-11.16
0.00
Opening Cash & Equivalents
7.84
3.40
1.68
10.10
11.07
3.88
1.58
12.74
0.00
Closing Cash & Equivalent
8.78
7.84
3.40
1.68
10.10
11.07
3.88
1.58
0.00

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
338.96
315.63
287.16
250.34
206.27
164.07
127.14
111.14
98.95
ROA
2.46%
5.45%
9.80%
10.52%
13.94%
14.71%
7.61%
5.99%
5.37%
ROE
5.54%
9.03%
13.46%
15.53%
22.76%
25.47%
13.35%
11.45%
11.38%
ROCE
7.76%
12.57%
17.18%
20.24%
30.83%
39.30%
18.10%
11.47%
14.23%
Fixed Asset Turnover
1.53
2.85
3.35
3.80
4.40
4.66
3.46
2.41
2.10
Receivable days
179.99
155.57
106.98
113.54
114.55
101.85
134.69
134.78
122.67
Inventory Days
70.42
49.06
32.72
39.53
41.06
30.72
39.13
45.19
39.31
Payable days
128.36
99.70
66.97
93.48
91.33
56.53
92.40
126.93
125.22
Cash Conversion Cycle
122.06
104.93
72.73
59.59
64.28
76.03
81.42
53.04
36.75
Total Debt/Equity
0.80
0.27
0.11
0.09
0.01
0.05
0.12
0.10
0.34
Interest Cover
5.60
10.07
22.35
36.44
38.93
40.77
14.60
9.26
7.29

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Bharat Parenterals’ arm clears USFDA inspection at manufacturing facility in Vadodara
    5th May 2025, 12:00 PM

    The inspection was conducted from April 28, 2025 to May 2, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.